RxDoctor Payments Data

Matthew Plante, MD

Sports Medicine · Providence, RINPI 1447477328

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 55.5% of the total. Reporting peaked in 2020 at $7,565 and has fallen 96.6% since, to $260 in 2024.

$14,767in general payments, 2019–2025

Across 65 payments — averaging $227.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$8K
  • Kairos Surgical Inc$2K
  • Prodigy Surgical Distribution, Inc.$2K
  • Arthrex$1K
  • Ferring Pharmaceuticals Inc.$226
  • Johnson & Johnson$208
  • plus $788 from 13 others

What the payments were for

  • Consulting fees$8,19055%
  • Travel & lodging$3,18822%
  • Food & beverage$2,18915%
  • Education$1,2008%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,767 in reported general payments places this provider in the 75th percentile of 28 sports medicine providers in Rhode Island.

See all sports medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$81,734
Medicare patients
157
Services billed
1,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen12$83
Meloxicam20$58

Paid to pharmacies, not to this prescriber.

Other sports medicine in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →